Paper7397697
Radiolabeling of antibodies.
Eckelman WC and 2 others. Cancer Res, 1980. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. Radiolabeling of antibodies. Papers, record 7397697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7397697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies | Major topic |
| Isotope Labeling | Major topic |
| Chelating Agents | |
| Chemical Phenomena | |
| Chemistry | |
| Humans | |
| Indium | |
| Iodine Radioisotopes | |
| Neoplasms | |
| Radiation Dosage | |
| Substrate Specificity | |
| Technetium |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36314010 | Immuno-PET: Design options and clinical proof-of-concept. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/36314010 | PubMed |
| 33632875 | A Novel Antibody-IL15 Fusion Protein Selectively Localizes to Tumors, Synergizes with TNF-based Immunocytokine, and Inhibits Metastasis. | Mol Cancer Ther | 2021 | https://conductscience.org/library/papers/33632875 | PubMed |
| 32579891 | Near-infrared fluorescence imaging in immunotherapy. | Adv Drug Deliv Rev | 2020 | https://conductscience.org/library/papers/32579891 | PubMed |
| 23928799 | Optimization of microfluidic PET tracer synthesis with Cerenkov imaging. | Analyst | 2013 | https://conductscience.org/library/papers/23928799 | PubMed |
| 20187791 | Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies. | Cancer Biother Radiopharm | 2010 | https://conductscience.org/library/papers/20187791 | PubMed |
| 8814727 | Applicability of short-lived radiometallic nuclide for high sensitivity two-site "sandwich" immunoradiometric assay: human growth hormone assay. | Ann Nucl Med | 1996 | https://conductscience.org/library/papers/8814727 | PubMed |
| 6409238 | Improved tumour localisation using indium-111 labelled antibodies. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6409238 | PubMed |
| 6352009 | Antitumor monoclonal antibodies for radioimmunodetection of tumors and drug targeting. | Cancer Metastasis Rev | 1983 | https://conductscience.org/library/papers/6352009 | PubMed |
| 6169388 | Localisation of malignant germ-cell tumours by external scanning after injection of radiolabelled anti-alpha-fetoprotein. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6169388 | PubMed |
| 4076233 | Immunoreactivity of monoclonal anti-melanoma antibodies in relation to the amount of radioactive iodine substituted to the antibody molecule. | Eur J Nucl Med | 1985 | https://conductscience.org/library/papers/4076233 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7397697
GET https://conductscience.org/api/papers/v1/7397697/authors